Effccts of belimumab,a B lymphocyte stimulator-specific inhibitor,on disease activity across multiplc organ domains in patients with systemic lupus crythematosus:combined results from two phase Ⅲ trials

查看全文 作　　者：Manzi;S;Sánchez-Gucrrcro;J;Merrill;JT